How might the CMS decision on Biogen’s Aduhelm impact other Alzheimer’s candidates? Markets April 10, 2022 [ad_1] selvanegra/iStock through Getty Photos Regardless of the Facilities for Medicare & Medicaid Providers’ (CMS) determination on April 7 to…
